2 ms·
Also sometimes these biotechs, if they have novel approaches, are sought by big pharma because they’re more agile. So they buy them out as their R&D labs or i
by mc32 6y ago
Also sometimes these biotechs, if they have novel approaches, are sought by big pharma because they’re more agile. So they buy them out as their R&D labs or invest in them for their IP.
- sjg007 6y agoThe "big bet" is on the phase 3.